Free Trial

Telix Pharmaceuticals (TLX) Institutional Ownership

Telix Pharmaceuticals logo
$10.52 +0.13 (+1.25%)
Closing price 04:00 PM Eastern
Extended Trading
$10.53 +0.01 (+0.10%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Telix Pharmaceuticals (NASDAQ:TLX)

Number of
Institutional Buyers
(last 12 months)
18
Total
Institutional Inflows
(last 12 months)
$14.51M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$1.59M
Get TLX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Telix Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TLX Institutional Buying and Selling by Quarter

Telix Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/12/2026 XY Capital Ltd12,552$120K0.1%N/A0.004%
4/27/2026 Private Advisor Group LLC174,415$1.67M0.0%+276.3%0.051%
2/18/2026Vident Advisory LLC27,249$204K0.0%N/A0.008%
2/18/2026XTX Topco Ltd11,820$89K0.0%N/A0.003%
2/18/2026Quadrature Capital Ltd36,828$276K0.0%N/A0.011%
2/18/2026OLD Mission Capital LLC14,799$111K0.0%N/A0.004%
2/18/2026Millennium Management LLC19,733$148K0.0%-90.0%0.006%
2/17/2026Lazard Asset Management LLC250,517$1.88M0.0%+118.6%0.074%
2/16/2026Mariner LLC36,582$274K0.0%N/A0.011%
2/13/2026Marshall Wace LLP46,658$349K0.0%-3.9%0.014%
2/12/2026 Jane Street Group LLC40,042$300K0.0%-45.1%0.012%
2/12/2026Portland Investment Counsel Inc.266,200$2.06M0.6%+108.0%0.079%
1/1/2026JPMorgan Chase & Co.25,355$243K0.0%N/A0.007%
11/17/2025Millennium Management LLC196,741$1.88M0.0%N/A0.058%
11/14/2025Lazard Asset Management LLC114,624$1.10M0.0%N/A0.034%
11/14/2025Portland Investment Counsel Inc.128,000$1.23M0.3%N/A0.038%
11/13/2025 Private Advisor Group LLC42,112$403K0.0%+67.3%0.012%
11/7/2025JPMorgan Chase & Co.25,355$243K0.0%N/A0.007%
11/6/2025 Rhumbline Advisers2,579$25K0.0%+117.3%0.001%
8/15/2025IHT Wealth Management LLC13,240$213K0.0%N/A0.004%
8/14/2025 Jane Street Group LLC35,103$564K0.0%N/A0.010%
8/13/2025 Russell Investments Group Ltd.60,301$975K0.0%N/A0.018%
8/5/2025Pier Capital LLC188,992$3.04M0.5%N/A0.056%
7/25/2025Vanguard Personalized Indexing Management LLC18,475$297K0.0%N/A0.005%
7/24/2025 Blair William & Co. IL13,500$217K0.0%N/A0.004%
5/9/2025ABC Arbitrage SA26,939$451K0.1%N/A0.008%
5/5/2025Private Advisor Group LLC10,140$170K0.0%N/A0.003%


TLX Institutional Ownership - Frequently Asked Questions

During the previous two years, 20 institutional investors and hedge funds held shares of Telix Pharmaceuticals. The most heavily invested institutionals were Pier Capital LLC ($3.04M), Portland Investment Counsel Inc. ($2.06M), Lazard Asset Management LLC ($1.88M), Private Advisor Group LLC ($1.67M), Russell Investments Group Ltd. ($975K), ABC Arbitrage SA ($451K), and Marshall Wace LLP ($349K).Learn more on Telix Pharmaceuticals' institutional investors.

Of the 19 institutional investors that purchased Telix Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Portland Investment Counsel Inc. ($266.20K), Lazard Asset Management LLC ($250.52K), Millennium Management LLC ($196.74K), Pier Capital LLC ($188.99K), Private Advisor Group LLC ($155.16K), Russell Investments Group Ltd. ($60.30K), and JPMorgan Chase & Co. ($50.71K).

Institutional investors have bought a total of 1,380,016 shares in the last 24 months. This purchase volume represents approximately $14.51M in transactions.

The following institutional investors have sold Telix Pharmaceuticals stock in the last 24 months: Millennium Management LLC ($177.01K), Jane Street Group LLC ($32.95K), and Marshall Wace LLP ($1.92K).

Institutional investors have sold a total of 211,873 shares in the last 24 months. This volume of shares sold represents approximately $1.59M in transactions.



This page (NASDAQ:TLX) was last updated on 5/13/2026 by MarketBeat.com Staff.
From Our Partners